Yuichi Taneyama
Overview
Explore the profile of Yuichi Taneyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Asano T, Morimoto A, Nakazawa A, Ueda T, Ogawa C, Sakata N, et al.
Int J Hematol
. 2025 Mar;
PMID: 40063331
Background: Rosai-Dorfman-Destombes disease (RDD) is a rare form of histiocytosis, characterized by the accumulation of S100 protein-positive and CD1a-negative histiocytes with emperipolesis. Recently, oncogenic mutations in mitogen-activated protein kinase pathway...
2.
Ando K, Nakamichi K, Hirose K, Taneyama Y, Kakuda H, Ochiai H
Rinsho Ketsueki
. 2025 Feb;
66(1):36-41.
PMID: 39924206
The patient was a 22-year-old man. 8 years ago, he developed T-cell lymphoblastic lymphoma and relapsed during treatment. He underwent HLA-haploidentical peripheral blood stem cell transplantation (PBSCT) from a related...
3.
Kato S, Nakashima K, Yamato G, Saito S, Taneyama Y, Yamamoto N, et al.
Pediatr Blood Cancer
. 2024 Aug;
71(10):e31244.
PMID: 39099137
Hypomethylating agent treatment for myeloid leukemia associated with Down syndrome (ML-DS) has been scarcely reported. Herein, we collected information on azacitidine treatment for ML-DS in Japan. Forty-eight cycles of azacitidine...
4.
Taneyama Y, Morimoto A, Ochiai H, Ando K, Kakuda H, Naruke Y, et al.
Int J Hematol
. 2024 Jul;
120(4):520-524.
PMID: 39003680
Rosai-Dorfman-Destombes disease (RDD) is a rare histiocytosis characterized by accumulation of S100 + , CD68 + , and CD1a- histiocytes, with emperipolesis. It occurs predominantly in black adolescents and young...
5.
Sato T, Yoshida K, Toki T, Kanezaki R, Terui K, Saiki R, et al.
Blood
. 2024 Mar;
143(25):2627-2643.
PMID: 38513239
Transient abnormal myelopoiesis (TAM) is a common complication in newborns with Down syndrome (DS). It commonly progresses to myeloid leukemia (ML-DS) after spontaneous regression. In contrast to the favorable prognosis...
6.
Hangai M, Kawaguchi T, Takagi M, Matsuo K, Jeon S, Chiang C, et al.
Haematologica
. 2023 Oct;
109(4):1247-1252.
PMID: 37881853
No abstract available.
7.
Miyamoto S, Urayama K, Arakawa Y, Koh K, Yuza Y, Hasegawa D, et al.
Pediatr Hematol Oncol
. 2023 May;
41(1):81-87.
PMID: 37129918
Germline genetic variants influence development of pediatric B cell acute lymphoblastic leukemia (B-ALL). Genome-wide association studies (GWAS) have identified several pediatric B-ALL susceptibility loci. and , transcription factors involved in...
8.
Biketova A, Gelardi M, Smith M, Simonini G, Healy R, Taneyama Y, et al.
J Fungi (Basel)
. 2022 Feb;
8(2).
PMID: 35205856
The boletoid genera and have recently been suggested by some researchers to constitute a single genus, and was merged into as a later synonym. However, no convincing arguments have yet...
9.
Tanaka Y, Yeoh A, Moriyama T, Li C, Kudo K, Arakawa Y, et al.
Haematologica
. 2021 Jan;
106(7):2026-2029.
PMID: 33504140
No abstract available.
10.
Urayama K, Takagi M, Kawaguchi T, Matsuo K, Tanaka Y, Ayukawa Y, et al.
Sci Rep
. 2018 Jan;
8(1):789.
PMID: 29335448
Genome-wide association studies (GWAS) performed mostly in populations of European and Hispanic ancestry have confirmed an inherited genetic basis for childhood acute lymphoblastic leukemia (ALL), but these associations are less...